183 related articles for article (PubMed ID: 7618286)
1. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Jul; 210(2):495-500. PubMed ID: 7618286
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation.
Mahalingam S; Khan SA; Jabbar MA; Monken CE; Collman RG; Srinivasan A
Virology; 1995 Feb; 207(1):297-302. PubMed ID: 7871742
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization.
Mahalingam S; Collman RG; Patel M; Monken CE; Srinivasan A
Virology; 1995 Oct; 212(2):331-9. PubMed ID: 7571402
[TBL] [Abstract][Full Text] [Related]
4. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles.
Mahalingam S; Patel M; Collman RG; Srinivasan A
Virology; 1995 Dec; 214(2):647-52. PubMed ID: 8553570
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
González SA; Affranchino JL
Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
[TBL] [Abstract][Full Text] [Related]
6. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
7. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest.
Zhou Y; Lu Y; Ratner L
Virology; 1998 Mar; 242(2):414-24. PubMed ID: 9514978
[TBL] [Abstract][Full Text] [Related]
8. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
Philippon V; Matsuda Z; Essex M
J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
[TBL] [Abstract][Full Text] [Related]
9. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect.
Kewalramani VN; Park CS; Gallombardo PA; Emerman M
Virology; 1996 Apr; 218(2):326-34. PubMed ID: 8610459
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
12. Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities.
Berglez JM; Castelli LA; Sankovich SA; Smith SC; Curtain CC; Macreadie IG
Biochem Biophys Res Commun; 1999 Oct; 264(1):287-90. PubMed ID: 10527879
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity.
Subbramanian RA; Yao XJ; Dilhuydy H; Rougeau N; Bergeron D; Robitaille Y; Cohen EA
J Mol Biol; 1998 Apr; 278(1):13-30. PubMed ID: 9571031
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
[TBL] [Abstract][Full Text] [Related]
16. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.
Depienne C; Roques P; Créminon C; Fritsch L; Casseron R; Dormont D; Dargemont C; Benichou S
Exp Cell Res; 2000 Nov; 260(2):387-95. PubMed ID: 11035935
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe.
Zhang C; Rasmussen C; Chang LJ
Virology; 1997 Mar; 230(1):103-12. PubMed ID: 9126266
[TBL] [Abstract][Full Text] [Related]
18. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ
Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823
[TBL] [Abstract][Full Text] [Related]
19. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.
Kootstra NA; Schuitemaker H
Virology; 1999 Jan; 253(2):170-80. PubMed ID: 9918876
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
